As reported previously, kidney-absorbed doses with [177Lu]Lu-PSMA-I&T are ~ 1.5x higher than with [177Lu]Lu-PSMA-617, potentially increasing the risk of nephropathy 46. This evidence concerns the gene FOLH1 and Nephropathy.